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2ABSTRACT:43
A few family of medicated Janus fibers that provides a highly tunable biphasic drug44
release were was fabricated using a side-by-side electrospinning process employing a45
Teflon-coated parallel spinneret. The coated spinneret facilitated the formation of a46
Janus Taylor cone and in turn high quality integrated Janus structures, which could not47
be reliably obtained without the Teflon coating. The fibers prepared had one side48
consisting of polyvinylpyrrolidone (PVP) K60 and ketoprofen, and the other of ethyl49
cellulose (EC) and ketoprofen. To modulate and tune drug release, PVP K10 was50
doped into the EC side in some cases. The fibers were linear and had flat51
morphologies with an indent in the center. They provide biphasic drug release, with52
the PVP K60 side dissolving very rapidly to deliver a loading dose of the active53
ingredient, and the EC side resulting in sustained release of the remaining ketoprofen.54
The addition of PVP K10 to the EC side was able to accelerate the second stage of55
release; variation in the dopant amount permitted the release rate and extent in the56
second, sustained, phase this phase to be precisely tuned. These results offer the57
potential to rationally design systems with highly controllable drug release profiles,58
which can complement natural biological rhythms and deliver maximum therapeutic59
effects.60
KEYWORDS: Janus fibers; side-by-side electrospinning; Teflon-coated spinneret;61
nano drug delivery systems; tunable release rates; structural nanocomposites62
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1. Introduction66
A range of “top-down” nanofabrication techniques exists, but of these67
electrohydrodynamic atomization (EHDA, including electrospinning, electrospraying68
and e-jet printing) is particularly attractive because of its simplicity and capability to69
propagate the structure of a macroscale template into a nanostructure [1,2]. An EHDA70
process typically involves preparing a solution of a polymer (possibly also with a71
functional component) in a volatile solvent. This solution is then ejected at a precisely72
controlled rate from a syringe fitted with a metal needle (spinneret) towards a73
grounded collector plate [3-7]. A large potential difference is applied between the74
spinneret and collector plate. This electrical energy causes very rapid evaporation of75
the solvent, leading to a solid product. The spatial distribution of components in the76
latter mirrors that in the spinneret.77
Considering a two-compartment system, the simplest structures are i) core-shell78
(with different interior and exterior) and ii) an asymmetric Janus structure, where the79
sides of the structure are different. Both can be used to develop materials with tunable80
or multifunctional properties. Core-shell structures, including fibers and particles,81
generated by EHDA have been widely explored [8,9]. These are most commonly82
fabricated from a concentric spinneret [10,11], although they can also be prepared83
using a single fluid process [12,13]. More complex structures such as three-layer84
nanofibers and microparticles (from tri-axial EHDA processes) and85
multi-compartmental structures from multiple fluid spinnerets have also been reported86
4[14,15]. However, there are very few publications reporting electrospun Janus fibers,87
although there are hundreds on electrospun core-shell nanofibers.88
Unlike core/shell architectures the Janus structure permits direct contact of both89
compartments with their environment, which can be very useful in the creation of90
multi-functional nanoscale products [16]. Such structure types are also commonly91
found in nature [17], and Janus nanoparticles are currently one of the one of the most92
high profile topics in the nano field [18,19]. In sharp contrast, very little attention has93
been paid to Janus fibers. Since Gupta and Wilkes first reported the fabrication of94
such Janus fibers using side-by-side electrospinning with polyvinyl95
chloride/polyurethane and polyvinyl chloride)/polyvinylidiene fluoride [20], only a96
very limited number of additional studies have followed their initial work [21-23].97
This can be attributed to the difficulty of creating integrated Janus nanostructures98
when parallel metal capillaries are used as a spinneret for side-by-side99
electrospinning.100
Biphasic controlled release of an active ingredient is much sought after in101
pharmaceutics, particularly with an initial rapid release stage followed by sustained102
release. Drug delivery systems (DDS) providing such release profiles can deliver an103
effective “loading dose”, producing a rapid rise in the plasma concentration of drug104
and rapidly relieving a patient’s symptoms. Subsequently, a prolonged-release phase105
maintains an effective therapeutic concentration, avoiding repeated administrations106
[24].107
Different types of biphasic release DDS for potential oral administration have108
5been reported, fabricated using a wide variety of technologies [25]. Biphasic release109
fibers from single fluid electrospinning have been generated through the encapsulation110
of nanoparticles in the fibers [26] or the collection of different types of fibers in a111
layer-by-layer manner [27]. However, the former method involved a complex112
multiple-step preparation process, and the layer-by-layer collection of different fibers113
often resulted in non-homogeneous products. Coaxial electrospinning can yield114
biphasic release DDSs in a single step, as a result of its ability to produce materials115
where the composition of the core and shell are different [24,25]. By changing the116
shell-to-core fluid flow rate ratio [24] or the concentration of drug in the working fluids117
[28], a tunable biphasic release profile with accurate control of the amount of drug118
released in the different phases can be realized.119
However, to date there are no reports describing the tuning of the release rate in120
the sustained phase of release in an electrospun biphasic DDS. Being able to precisely121
control the rate of sustained release is important to ensure the most effective and safe122
pharmacokinetic profile for a particular disease, and to facilitate maximum absorbance123
of the drug after oral administration. For many drugs, absorption is moderately slow in124
the stomach, rapid in the proximal intestine, and declines sharply in the distal segment125
of the intestine [29].126
In this work, we aimed to develop a new side-by-side electrospinning process for127
creating integrated Janus fibers. A new Teflon-coated spinneret was exploited to ensure128
the two working fluids converge before they were ejected from the spinneret. A series129
of ketoprofen-loaded Janus fibers has been prepared using poly(vinylpyrrolidone)130
6(PVP) K60 and ethyl cellulose (EC). The fibers exhibit biphasic drug release, with an131
initial burst release followed by sustained freeing of drug into solution. The release rate132
and extent in the second phase can be tuned by doping small amounts of PVP K10 into133
the EC side of the fiber systems. As a result, nanoscale drug delivery systems with134
highly tunable release profiles have been produced; these cannot easily be achieved135
using traditional pharmaceutical technologies, and thus this work offers the potential to136
lead to a range of new medicines and concomitant patient benefit.137
2. Experimental138
2.1. Materials139
Polyvinylpyrrolidone K60 (PVP K60, Mw=360,000) and PVP K10 (Mw=10,000) were140
purchased from Sigma-Aldrich Ltd. (Shanghai, China). Ethyl cellulose (EC, 6mPa·s to141
9 mPa·s) was obtained from the Aladdin Chemistry Co. Ltd. (Shanghai, China).142
Keteprofen (KET) was purchased from the Wuhan Fortuna Chemical Co. Ltd. (Hubei,143
China). Methylene blue and anhydrous ethanol were obtained from the Sinopharm144
Chemical Reagent Co. Ltd. (Shanghai, China). All other chemicals used were145
analytical grade. Water was doubly distilled immediately prior to use.146
2.2. Side-by-side electrospinning147
After initial optimization experiments, the solutions used for electrospinning148
consisted of (1) 8% (w/v) PVP K60 and 2% (w/v) KET in ethanol, and (2) 24% (w/v)149
EC, 2% (w/v) KET and a varied content of PVP K10 (0, 1, 2, and 5% (w/v)) in ethanol.150
Two homemade side-by-side spinnerets were used for electrospinning. A flat151
piece of cardboard covered with aluminum foil was earthed and used as the collector152
7plate. Two syringe pumps (KDS100 and KDS200, Cole-Parmer®, Vernon Hills, IL,153
USA) were used to drive the working fluids. A ZGF 60kV/2mA power supply154
(Shanghai Sute Corp., Shanghai, China) was employed to provide a potential155
difference between the spinneret and collector.156
Electrospinning was conducted under ambient conditions (24 ± 2 °C with a157
relative humidity of 51 ± 7 %). After optimization, the applied voltage was fixed at 12158
kV, the fiber to collector distance at 20 cm and the flow rates of both the PVP K60 and159
EC solutions set to 1.0 mL/h. The electrospinning processes were recorded using a160
digital video recorder (PowerShot A490, Canon, Tokyo, Japan).161
2.3. Characterization162
2.3.1. Morphology and structure163
The morphologies of the fiber products were investigated using a Quanta FEG450164
field-emission scanning electron microscope (FESEM, FEI Corporation, Hillsboro,165
USA). The samples were subjected to gold sputter-coating in a nitrogen atmosphere166
prior to imaging. Average sizes (diameters for monolithic nanofibers and widths for167
Janus fibers) were determined by measuring the fibers at more than 100 different168
places in FESEM images, using the Image J software (National Institutes of Health,169
Bethesda, USA).170
The fiber structures were also studied on a JEM 2100F field-emission171
transmission electron microscope (TEM, JEOL, Tokyo, Japan). TEM samples were172
prepared by placing a lacey carbon-coated copper grid on the fiber collector and173
electrospinning onto it for several minutes.174
82.3.2. Functional performance175
In vitro dissolution tests were conducted according to the Chinese Pharmacopoeia176
(2010 ed.) Method II, a paddle method. Experiments were undertaken using a RCZ-8A177
dissolution apparatus (Tianjin University Radio Factory, Tianjin, China).178
A mass of fibers containing 40 mg KET (200, 519, 360, 370, 381 and 408 mg for179
fibers F1, F2, F3, F4, F5 and F6, respectively) was placed in 800 mL physiological180
saline (PS, 0.9% wt) at 37 ± 1 °C, providing sink conditions with C < 0.2Cs. The181
dissolution vessels were stirred at 50 rpm. At predetermined time points, 5.0 mL182
aliquots were withdrawn from the dissolution medium and replaced with fresh PS to183
maintain a constant volume. After filtration through a 0.22 µm membrane (Millipore,184
Billerica, USA) and appreciate dilution with PS, the samples were analyzed at λmax =185
260 nm using a UV-vis spectrophotometer (UV-2102PC, Unico Instrument Co. Ltd.,186
Shanghai, China). The accumulative KET released was back-calculated from the data187
obtained against a predetermined calibration curve. All experiments were repeated six188
times, and results given as mean ± S.D.189
3. Results and discussion190
3.1. Implementation of the side-by-side electrospionning191
Traditionally, a side-by-side spinneret comprises two parallel metal capillaries.192
Here, we used a section of Teflon tube to coat the parallel metal capillaries on their193
outlets and project slightly over their nozzles (see the Supplementary Information, Fig.194
S1). The Teflon coating has several advantages: 1) it can effectively prevent the195
separation of the two working fluids, which occurs when a traditional parallel196
9spinneret is used; 2) an even distribution of charge around the spinneret is expected to197
be achieved; 3) because Teflon is non-conductive, all the charge from the power198
supply can be directed effectively to the working fluids [25]; 4) the non-stick nature of199
Teflon will mean that fibers should not stick to the spinneret, and thus clogging can be200
avoided. These factors should all facilitate the formation of a Janus Taylor cone [30].201
Table 1. Details of the electrospinning processes and the resultant products.202
203
a This fluid consisted of PVP K60 (8% w/v) and KET (2% w/v)204
b Values are shown as mean ± S.D. For F1 and F2, ‘‘size’’ refers the fiber diameter, and for F3 to F6 to the full205
width of the combined Janus fibers.206
c P is the total drug content in the solid fibers calculated according to the flow rate and drug content in the fluids: P207
= [(Fp×Cpd) + (Fe×Ced)]/[(Fp×Cpa) + (Fe×Cea)] × 100%. Fp and Fe are the flow rates of the PVP side and EC side,208
respectively; Cpd and Ced the drug contents in PVP and EC sides; and Cpa and Cea the total solute content in the PVP209
and EC solutions.210
211
In this study six different fibers, two monolithic and four Janus, were prepared.212
Details of the electrospinning processes are given in Table 1. The apparatus deployed213
for side-by-side electrospinning is shown in Fig. 1a. The Teflon-coated spinneret was214
mounted on a polypropylene syringe containing a PVP K60 solution. The syringe was215
then placed vertically above the collector. A second syringe containing an EC solution216
was connected to the second capillary of the spinneret via a flexible silicone tube. For217
easy observation of the electrospinning processes, 0.001% (w/v) of methylene blue218
No. Process
PVP K60 side a EC side
Size b (µm)
P c
(%)
Flow rate
(mL/h)
Flow rate
(mL/h)
Composition (% w/v)
EC KET PVP K10
F1 Single 1.0 -- -- 0.57±0.09 20
F2 Single -- 1.0 24 2 0 0.68±0.13 7.7
F3 Side-by-side 1.0 1.0 24 2 0 0.92±0.10 11.1
F4 Side-by-side 1.0 1.0 24 2 1 1.02±0.17 10.8
F5 Side-by-side 1.0 1.0 24 2 2 0.98±0.13 10.5
F6 Side-by-side 1.0 1.0 24 2 5 1.06±0.12 9.8
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was added to the EC solution.219
After a series of optimization experiments, a stable electrospinning process was220
achieved, as depicted in Fig. 1b. A straight fluid jet was emitted from a Janus Taylor221
cone (Fig. 1c), followed by an unstable region of bending and whipping with coils of222
increasing size. The resultant fiber mat was light blue, with an even blue hue across223
the product. This was attributed to the presence of methylene blue; the homogeneous224
color distribution is indicative of an integrated Janus structure.225
In contrast, when the process was performed without the Teflon coating the fiber226
mat had an uneven blue color (Fig. 1d), demonstrating a failure to generate integrated227
and homogeneous structures. The two fluids used for electrospinning were observed228
to separate from one other immediately upon exiting the spinneret (Fig. 1e). When229
two fluids are ejected from the nozzles of a side-by-side spinneret, there is only a very230
small contact area between them. Since they originate in different capillaries, both231
fluids will be charged prior to coming into contact and thus it is inevitable that they232
will repel one another, preventing them from converging to form a Janus Taylor cone;233
this is illustrated in Fig. 1f(A). This initial repulsive force, Ft , leads to two Taylor234
cones; it is then followed by further repulsion between the two straight fluid jets (Fs)235
and the two bending and whipping coils (Fc). These factors result in the failure to236
form integrated Janus structures. When the spinneret was coated with Teflon (Fig.237
1f(B)), the two fluids are found to first converge, before forming a compound Taylor238
cone and ultimately resulting in integrated Janus structures.239
240
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Fig. 1. The side-by-side electrospinning process: (a) The experimental apparatus263
(inset: the connection of the side-by-side spinneret with the working fluids and power264
supply); (b) a photograph of a typical side-by-side electrospinning process with the265
Teflon-coated spinneret; (c) a Janus Taylor cone formed with the Teflon-coated266
spinneret; (d) the fiber mat from side-by-side electrospinning with the uncoated267
side-by-side spinneret; (e) the separation of fluids when using the uncoated spinneret;268
(f) an illustration of the role played by the Teflon coating: A - the separation of fluids269
arising from repulsive forces Ft (between the two Taylor cones), Fs (between the two270
straight fluid jets) and Fc (between the two coils); and B - the formation of an271
integrated Janus Taylor cone with the Teflon coating.272
3.2. Morphologies and structures of the fabricated Janus nanofibers273
First, the monolithic fibers F1 and F2 were prepared by single fluid274
12
electrospinning using the traditional side-by-side spinneret with one fluid turned off.275
Both fluids individually were found to have good electrospinnability. FESEM images276
of F1 (PVP K60 and KET) are shown in Fig. 2a. The fibers have a linear morphology277
and smooth surfaces, and an average diameter of 0.57 ± 0.09 µm. The FESEM images278
of F2 (EC and KET) are depicted in Fig. 2b; again the fibers are smooth and linear,279
possessing an average diameter of 0.68 ± 0.13 µm.280
The FESEM images of the Janus fibers F3, F4, F5 and F6 are exhibited in Fig. 2c281
to Fig 2f. All have linear morphologies and smooth surfaces. While the monolithic282
fibers are cylindrical in shape, these fibers have a flat concave topography but are still283
linear and smooth. The two sides of the fibers can clearly be resolved. The fiber284
diameters can be found in Table 1. F4 to F6 contain small amounts of PVP K10 doped285
into the EC side of the fibers, but this is found to have no significant influence on286
their size or morphology.287
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Fig. 2. FESEM images of the fibers, together with their size distributions: (a) F1299
(drug-loaded PVP fibers); (b) F2 (drug-loaded EC fibers); and the Janus PVP/EC/KET300
fibers (c) F3; (d) F4; (e) F5; (f) F6.301
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TEM images of F3, F4, F5 and F6 are displayed in Fig. 3a to Fig. 3d. Two302
different sides to the fibers can again be discerned, with the larger and slightly darker303
side being the EC compartment. In the TEM image of F3 (Fig. 3a), there is a central304
region with a lower contrast level, suggesting a concave topography. F4 (Fig. 3b)305
shows forks resulting from separation of the two sides of the fiber.306
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Fig. 3. TEM images of (a) F3; (b) F4; (c) F5; (d) F6.319
3.3. In vitro dissolution tests320
All the prepared six types of fibers are polymeric composites with KET321
presenting in an amorphous status state due to the the existence of hydrogen bonding322
and hydrophobic interactions between the drug and its carrier (see the Supplementary323
Information, Figs. S2 to S4). In the in vitro dissolution tests, the monolithic PVP324
fibers F1 provide a very fast drug release profile, freeing all the loaded drug within325
one minute (Fig. 4a and Table 2). This can be attributed to the large surface area and326
small diameter of the individual nanofibers, the porous 3D web structures of the fiber327
mats, the highly hydrophilic and fast-dissolving nature of PVP, and the amorphous328
state of KET in the fibers. In contrast, the F2 (EC) fibers give a sustained release329
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profile (Fig. 4a and Table 2), with release of 10.7% and 33.4% in the first minute and330
first hour, respectively. After 24 h, 82.5% of the embedded KET has been released.331
The Janus fibers F3 to F6 result in biphasic drug release profiles, with part a portion332
of the embedded drug being released rapidly into the dissolution medium with the333
dissolution of the PVP side of the fibers. Subsequently, the EC side of the fibers leads334
to sustained release of KET (Fig. 4a and Table 2). The addition of small amounts of335
PVP K10 to the EC side of the fibers permits the release in the second, sustained,336
phase to be tuned. An increase in PVP K10 content causes the release rate and the337
percentage released after 24h to increase correspondingly (Fig. 4b and Table 2). The338
F6 fibers, with 16.1% w/w PVP K10 in the EC side, released all the incorporated drug339
within 16 h.340
The second phase of the in vitro dissolution data (up to 16 h) was analyzed using341
the zero-order equation and Peppas equations:342
Zero-order equation [31]: Qz= a + r tz343
(where Qz is the release percentage, tz is the time, a is a constant and r is the release344
rate).345
Peppas equation: Qp = ktpn346
(where Qp is the release percentage, tp is the time, k is a constant and n is an exponent347
that indicates the release mechanism).348
The results of this analysis are shown in Table 2. Release from the EC side of the349
fibers appears to follow a typical Fickian diffusion mechanism; the values of the350
exponent n are all smaller than 0.45. The zero-order equation provides a simple way351
15
to compare the release rate (r) from the EC side of the different Janus fibers. As the352
content of PVP K10 (C) in the EC side was increased from 0% to 3.7%, 7.1% and353
16.1% w/w, the r values increased correspondingly from 2.16, to 2.31, 2.38 and 2.65354
h-1, respectively. A linear relationship can be established: r = 2.1756+0.0297C355
(R=0.9964; Fig. 4b). This demonstrates that the drug release rate from the EC matrix356
can be easily manipulated through doping with hydrophilic PVP K10.357
358
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Fig. 4. The release of KET from the electrospun nanofibers: (a) the in vitro KET368
release profiles from the six fibers; (b) the variation of the release percentage and rate369
in the second phase as a function of the PVP K10 content in the EC side of the fibers.370
371
Table 2. Data on the release of KET from the drug-loaded fibers a,b (n=6).372
373
Fiber
First phase
(1 min, %)
Rel after
24 h
(%)
Second phase of release
Relc
(%)
Regressed equation (to 16h)
Peppas Zero-order
F1 100±2.8 -- -- -- --
F2 10.7±2.2 82.5±5.3 --
Qp2=33.46t p2 0.3252
(R p2=0.9982)
--
F3 50.4±3.9 91.5±4.7
41.1
(41.5)
Q p3=54.61t p3 0.1576
(R p3=0.9921)
Qz3=54.62+2.16t z3
(R z3=0.9773)
F4 51.4±4.4 94.7±5.1
43.3
(44.7)
Q p4=55.54t p40.1621
(R p4=0.9932)
Qz4=55.44+2.31 t z4
(R z4=0.9798)
F5 52.3±4.7 98.4±4.3
46.1
(48.4)
Q p5=59.78t p5 0.1525
(R p5=0.9899)
Qz5=58.71+2.38 t z5
(R z5=0.9710)
F6 54.7±5.2 100.2±3.2 45.5 Q p6=62.53t p6 0.1624 Qz6=61.61+2.65 t z6
16
(50.2) (R p6=0.9927) (R z6=0.9693)
374
a The burst release in the first minute is defined as the first phase, and the data between the first minute and 16h375
were used to determine the drug release equations.376
b Abbreviations: Qp2, tp2, and R p2 refer to the release percentage, time and correlation coefficient calculated with the377
Peppas equation for F2. Qz2, tz2, and Rz2 are the release percentage, time and correlation coefficient determined with378
the zero-order equation for nanofibers F2. Quantities are defined similarly for the other fibers; the numerical379
subscript gives the identity of the fiber sample under consideration.380
c The percentage released in the second phase was calculated by subtracting the percentage of drug released in the381
first stage from the release percentage after 24 h. The values in brackets represent the percentage of the total382
amount of drug release which came from the EC sides (i.e. the drug content released after 24 h minus 50%, the383
amount of drug in the PVP side of the fibres).384
3.4. Drug release mechanism385
To investigate the drug release mechanism, samples were recovered from the386
dissolution apparatus after 24h and dried in air. The SEM results, shown in Fig. 5a to387
5d, show the morphologies of the EC side of the fibers (the PVP side dissolves388
completely in a few seconds). Although the overall Janus fibers did not appear to be389
affected by the addition of PVP K10 to the EC side, the size of the fibers recovered390
after 24h of dissolution appears to decrease with an increase of PVP K10 content, and391
they have increasingly curved morphologies (see the Supplementary Information, Fig.392
S5). The remnant nanofibers had rough and wrinkled surfaces, displaying holes and393
grooves; larger PVP K10 contents appear to promote more of these features.394
395
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Fig. 5. FESEM images of the fibers remaining after 24h of dissolution and the405
proposed drug release mechanism. (a) to (d) show the remains of fibers F3 to F6406
respectively; (e) is a schematic diagram explaining the mechanism of drug release407
from the Janus fibers.408
A potential mechanism underlying the biphasic release profile is given in Fig. 5e.409
After encountering water, the PVP K60 side of the Janus fibers will dissolve very410
rapidly and immediately free all the drug it contains. The remaining EC side provides411
the sustained release phase. When there is no PVP K10 in the EC side, as the case of412
F3, water diffuses into the EC matrix very slowly. KET is a poorly water soluble drug,413
and thus the dissolution of KET and its diffusion from the interior of the fibers to the414
dissolution medium proceed very slowly. Because EC is totally insoluble in water, it is415
inevitable that a certain amount of KET will remain trapped in the fibers and cannot be416
released even after 24h.417
The PVP K10 doped in the EC side of the fibers is highly soluble in water, and418
thus will dissolve rapidly on encountering water. As it does so, it will generate holes419
and pores in the EC matrix. The presence of increased amounts of PVP K10 will420
enhance this effect. The pores formed after dissolution of PVP K10 will facilitate the421
diffusion of water to the interior of the EC matrix, and of KET molecules into the422
dissolution media. This in turn increases the drug release rate and amount in the second423
phase of release. Further increases of PVP K10 content will yield interconnected pores,424
further aiding the movement of water into and drug out of the inside of the fibers, as is425
the case in for the Janus fibers F6 (Fig. 5d).426
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As a counterpart of the core-shell structure, the Janus structure can be exploited427
to develop a wide variety of functional and multi-functional nanomaterials [32]. The428
side-by-side electrospinning process reported here is easy to undertake, and our429
results should expand the possibilities for exploiting electrospinning to fabricate novel430
functional nanocomposites with Janus morphology. There are many possibilities for431
the use of such materials in developing new biomedical materials, in addition to the432
tunable biphasic release systems reported here. For example, the fibers could be433
exploited to develop systems permitting the controlled release of multiple drugs for a434
combined therapy, or for new wound dressings with one side providing adhesive and435
anti-inflammatory functions and the other providing sustained release of the active436
ingredients required for wound healing. By collecting Janus nanofibers in an aligned437
[33] or layer-by-layer fashion [34] additional strategies can be conceived for438
generating novel structures and building new structure-property-activity relationships.439
Furthermore, coaxial electrospinning allows the field of materials which can be440
electrospun to be broadened considerably, as often electrospinning can be achieved441
with only one of the two working fluids being electrospinnable on its own [35].442
Similarly, it might be possible to implement side-by-side electrospinning using one443
spinnable and one unspinnable fluid. This possibility is being studied at present. Much444
work has been undertaken to explore the scalability of single-fluid electrospinning445
[36,37], with very promising results. Hence, the generation of Janus fibers on a large446
scale should be eminently possible, and the novel nanoscale DDS which can be447
generated using such fibers have the real possibility for clinical translation [38].448
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4. Conclusion449
In summary, here we developed a Teflon-coated spinneret which could be used for450
produced highly effective and stable side-by-side electrospinning. The use of a Teflon451
coating can effectively prevent the separation of the two working fluids seen when452
attempting electrospinning with no coating. A series of medicated Janus fibers was453
successfully fabricated; these comprised two had two distinct sides respectively made454
of poly(vinylpyrrolidone) (PVP) K60 and ethyl cellulose (EC), loaded with ketoprofen455
(KET) as a model active ingredient. PVP K10 was added to the EC side of the fibers in456
some cases, to act as a porogen. Electron microscopy SEM and TEM images clearly457
demonstrated that integrated Janus fiber structures were produced, in which the KET458
was found to be amorphously distributed. In vitro dissolution tests demonstrated that459
all the Janus fibers were able to provide a biphasic controlled release profile, with an460
initial burst followed a slower and sustained release phase. By varying the amount of461
PVP K10 doped in the EC side of the fibers, the release rate and total release462
percentage can be precisely tuned. Our results proffer a platform for designing novel463
drug delivery systems that can provide a tunable release profile designed to464
complement natural biological rhythms for maximum therapeutic effects.465
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Captions of Tables and Figures544
Table 1. Details of the electrospinning processes and the resultant products.545
Table 2. Data on the release of KET from the drug-loaded fibers a,b (n=6).546
Fig. 1. The side-by-side electrospinning process: (a) the experimental apparatus (inset: the547
connection of the side-by-side spinneret with the working fluids and power supply); (b) a548
photograph of a typical side-by-side electrospinning process with the Teflon-coated spinneret;549
(c) a Janus Taylor cone formed with the Teflon-coated spinneret; (d) the fiber mat from550
side-by-side electrospinning with the uncoated side-by-side spinneret; (e) the separation of551
fluids when using the uncoated spinneret; (f) an illustration of the role played by the Teflon552
coating: A - the separation of fluids arising from repulsive forces Ft (between the two Taylor553
cones), Fs (between the two straight fluid jets) and Fc (between the two coils); and B - the554
formation of an integrated Janus Taylor cone with the Teflon coating.555
Fig. 2. FESEM images of the fibers, together with their size distributions: (a) F1 (drug-loaded556
PVP fibers); (b) F2 (drug-loaded EC fibers); and the Janus PVP/EC/KET fibers (c) F3; (d) F4;557
(e) F5; (f) F6.558
Fig. 3. TEM images of (a) F3; (b) F4; (c) F5; (d) F6.559
24
Fig. 4. The release of KET from the electrospun nanofibers: (a) the in vitro KET release560
profiles from the six fibers; (b) the variation of the release percentage and rate in the second561
phase as a function of the PVP K10 content in the EC side of the fibers.562
Fig. 5. FESEM images of the fibers remaining after 24h of dissolution and the proposed drug563
release mechanism. (a) to (d) show the remains of fibers F3 to F6 respectively; (e) is a564
schematic diagram explaining the mechanism of drug release from the Janus fibers.565
566
